drugset / Trial / NCT00003220

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

NCT00003220

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with metastatic colorectal cancer.

Timeline

Start
1998-02
Primary completion
2000-11
Completion
2001-06

Drugs

EvaluationDrugModalityDoseRoute
Subject bryostatin 1 Small molecule Intravenous

Indications